• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to 1-(1,2-oxazol-3-yl)ethan-1-amine (CAS No. 1008985-14-5)

The compound 1-(1,2-oxazol-3-yl)ethan-1-amine, identified by the CAS number 1008985-14-5, is a significant molecule in the realm of pharmaceutical chemistry and bioorganic synthesis. Its structural framework, featuring an oxazole ring linked to an amine-substituted ethyl group, positions it as a versatile intermediate in the development of novel therapeutic agents. This introduction delves into the compound's chemical properties, synthetic pathways, and its emerging role in contemporary medicinal chemistry research.

The molecular structure of 1-(1,2-oxazol-3-yl)ethan-1-amine encompasses a heterocyclic oxazole core, which is known for its stability and ability to participate in various chemical reactions due to the presence of two nitrogen atoms. The oxazole ring is appended to an ethyl chain via an amine functional group (–NH?), which serves as a nucleophilic site for further derivatization. This bifunctional nature makes the compound particularly valuable in synthetic chemistry, allowing for the construction of more complex molecules through nucleophilic substitution, condensation reactions, or metal-catalyzed coupling processes.

In recent years, there has been growing interest in oxazole derivatives due to their broad spectrum of biological activities. The oxazole scaffold is found in numerous natural products and pharmacologically active compounds, exhibiting properties such as antimicrobial, anti-inflammatory, and anticancer effects. The amine group in 1-(1,2-oxazol-3-yl)ethan-1-amine not only enhances its reactivity but also suggests potential applications in the synthesis of bioactive molecules that require amine-based interactions with biological targets.

The synthesis of 1-(1,2-oxazol-3-yl)ethan-1-amine typically involves multi-step organic transformations starting from readily available precursors. One common approach involves the reaction of 2-aminoethylamine with 2-halo-substituted oxazole derivatives under controlled conditions. The halo group on the oxazole ring can be displaced by the aminoethyl group via nucleophilic aromatic substitution (SNAr), yielding the desired product. Alternatively, reductive amination or cyclocondensation strategies may be employed depending on the specific synthetic route chosen.

Recent advancements in synthetic methodologies have improved the efficiency and scalability of producing 1-(1,2-oxazol-3-yl)ethan-1-amine. For instance, transition-metal-catalyzed cross-coupling reactions have been explored to streamline the connection between the oxazole and ethylamine moieties. Palladium-catalyzed Buchwald-Hartwig amination or copper-mediated Ullmann coupling can provide high yields under mild conditions while minimizing byproduct formation. These innovations are particularly relevant in industrial settings where cost-effectiveness and environmental considerations are paramount.

The pharmacological potential of 1-(1,2-oxazol-3-yl)ethan-1-amine has been explored in several preclinical studies. Researchers have investigated its derivatives as inhibitors of enzymes involved in inflammatory pathways or as modulators of receptor activity. The oxazole ring's ability to engage with biological targets such as proteins or nucleic acids makes it a valuable scaffold for drug design. Additionally, computational modeling and virtual screening techniques have been employed to identify promising analogs of this compound that may exhibit enhanced potency or selectivity.

In particular, derivatives of 1-(1,2-oxazol-3-yl)ethan-1-amine have shown promise in addressing neurological disorders. The oxazole moiety's structural similarity to certain neurotransmitter analogs suggests its potential as a tool compound for studying neural signaling pathways. Furthermore, modifications at the amine group can fine-tune pharmacokinetic properties such as solubility and metabolic stability, which are critical factors in drug development.

The role of 1-(1,2-oxazol-3-ylolethanammonium chloride) (a salt form derived from this compound) in medicinal chemistry cannot be overstated. Its salt form enhances solubility and bioavailability, making it more suitable for formulation into pharmaceutical products. This has spurred interest among medicinal chemists to explore its use as a lead compound or intermediate in synthesizing novel therapeutics targeting diseases such as cancer or autoimmune conditions.

Future directions in the study of 1-(1,2-oxtzol-x)-ethyl-x-ammonium hydrochloride (a variation highlighting different substituents) include exploring its role in combination therapies. By pairing this compound with other bioactive molecules or therapeutic agents, researchers aim to develop synergistic effects that could improve treatment outcomes for complex diseases. Additionally, green chemistry principles are being integrated into its synthesis to reduce environmental impact while maintaining high yields and purity standards.

In conclusion,(Z)-N-[4-[[(E)-(4-chlorophenyl)methylene]-thiazolidin]-2-carboxamido]benzamide, another derivative sharing structural motifs with our primary compound, highlights how modifications can yield compounds with distinct biological activities yet retaining core functionalities beneficial for drug design.* The continued investigation into compounds like (E)-N'-[4-[[(E)-(4-chlorophenyl)methylene]-thiazolidin]-2-carboxamido]benzamide* underscores their significance in modern pharmaceutical research.* As synthetic methods evolve,* so too does our ability* to harness* these versatile intermediates* for* developing* innovative treatments.*

• 1211535-89-5(1-(5-Methyl-1,2-oxazol-3-yl)ethan-1-amine)
• 957187-55-2(1-(5-Ethyl-1,2-oxazol-3-yl)ethanamine)
• 1401526-13-3(2-(1,2-Oxazol-3-yl)propan-2-amine)
• 893763-10-5(methyl1-(1,2-oxazol-3-yl)ethylamine)
• 1522774-96-4(1-Isoxazol-3-yl-cyclopropylamine)
• 1255147-67-1(3-(pyrrolidin-2-yl)-1,2-oxazole)
• 1808068-52-1(1-(5-Methylisoxazol-3-yl)ethanamine)
• 1082746-81-3(1-(1,2-Oxazol-3-yl)ethan-1-amine hydrochloride)
• 131052-58-9(1,2-oxazol-3-ylmethanamine)
• 1807921-05-6((1R)-1-(5-methyl-1,2-oxazol-3-yl)ethan-1-amine hydrochloride)